期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 153, 期 4, 页码 421-436出版社
WILEY
DOI: 10.1111/j.1365-2141.2011.08595.x
关键词
flow cytometry; aberrant antigen expression; acute myeloid leukaemia; myelodysplastic syndromes; minimal residual disease
类别
P>This article reviews the use of aberrant antigen expression detected by flow cytometry in the diagnosis and clinical handling of acute myeloid leukaemia (AML) and the myelodysplastic syndromes (MDS). Such aberrancies offer a valuable tool for the proper classification of these myeloid malignancies according the World Health Organization 2008 classification. Aberrant antigen expression by flow cytometry is also important for prognostification. This review supports the view, that minimal residual disease detection methods that make use of such aberrancies should be part of the routine management of AML patients to guide therapy, but also suggests the introduction of flow cytometry in MDS for diagnosis and treatment decisions in the near future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据